Breaking News
Sort by:
Top Post
New Two-year Data Confirm Roche’s Vabysmo Improves Vision With Fewer Treatments for People With Neovascular Age-related Macular Degeneration
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new two-year data from the TENAYA and […]
Obesity Linked to Damaging Changes in Failing Hearts
Obesity is linked to changes in the structure and pumping action of the heart before […]
Frozen Eggs More Efficient Option than IVF for Women Starting Families Later
The largest U.S. report of elective fertility preservation outcomes to date found that 70 percent […]
CHOP Researchers Develop New Computational Tool to Interpret Clinical Significance of Cancer Mutations
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new tool to help researchers interpret […]
Twice-yearly Injection to Treat High Blood Pressure Could Replace Daily Pills
If successful, the study by Queen Mary University of London and Barts Health NHS Trust […]
Minnesota Neurosurgeon Among First in Country to Perform Navigated Spine Fusions With Inspired Spine OLLIF Technology | Pharmtech Focus
Dr. Uzma Samadani, A Minneapolis neurosurgeon renowned for spine tumor resection and complex neurotrauma repair has completed 4 […]
Structure of a Bacterial "Drug Pump" Reveals New Way to Counter Hospital-borne Infection
By revealing the structure of a protein used by bacteria to pump out antibiotics, a […]
Researchers Discover New Model for "Global" DNA Repair
Two studies provide a radically new picture of how bacterial cells continually repair damaged sections […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more